1. Home
  2. LEGN vs MC Comparison

LEGN vs MC Comparison

Compare LEGN & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$22.14

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Logo Moelis & Company

MC

Moelis & Company

HOLD

Current Price

$77.16

Market Cap

5.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEGN
MC
Founded
2014
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
5.3B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
LEGN
MC
Price
$22.14
$77.16
Analyst Decision
Strong Buy
Buy
Analyst Count
13
9
Target Price
$69.33
$74.13
AVG Volume (30 Days)
2.1M
723.6K
Earning Date
11-12-2025
02-04-2026
Dividend Yield
N/A
3.35%
EPS Growth
N/A
446.16
EPS
N/A
3.17
Revenue
$909,045,000.00
$1,467,580,000.00
Revenue This Year
$68.20
$27.41
Revenue Next Year
$47.77
$18.00
P/E Ratio
N/A
$24.45
Revenue Growth
74.75
51.19
52 Week Low
$20.21
$47.00
52 Week High
$45.30
$82.89

Technical Indicators

Market Signals
Indicator
LEGN
MC
Relative Strength Index (RSI) 42.47 66.67
Support Level $20.21 $71.53
Resistance Level $24.12 $75.35
Average True Range (ATR) 1.05 2.34
MACD 0.30 0.23
Stochastic Oscillator 47.57 90.81

Price Performance

Historical Comparison
LEGN
MC

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Share on Social Networks: